Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: María Reig Vittorina Zagonel Lorenza Rimassa Nicola Personeni Brian Schwartz Vincenzo Mazzaferro Jordi Bruix Armando Santoro Thomas Decaens Carlos Lopez Lopez |
| Publication date | April 3, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |